Completion of the Icatibant Outcome Survey and What We Learned

Key Points

• The aim is to evaluate the long-term safety and effectiveness of icatibant in treating hereditary angioedema.
• Creation of an observational registry for monitoring over 15 years
• Data collection on icatibant use
• Assessment of safety and effectiveness outcomes
• Icatibant demonstrated effectiveness in managing hereditary angioedema symptoms
• No new safety concerns were identified over the 15 years of use